In a judgment delivered on 14 October 2026, the High Court of Australia set an important precedent for return-resident visa holders by allowing the appeal in Morton v Minister for Immigration and Citizenship ([2026] HCA 38). The applicant had been refused a Resident Return (Class BB) visa after a delegate concluded he posed an unacceptable risk to the community. The Court found the delegate failed to consider critical evidence about the applicant’s access to medication and therapy in Singapore, breaching sections 54 and 55 of the Migration Act and denying procedural fairness. It also held that the risk-assessment reasoning was “illogical or irrational,” reinforcing the requirement that visa decisions be grounded in cogent evidence. For corporate assignees and long-term expatriates who rely on Resident Return visas to maintain Australian permanent residence while abroad, the ruling underscores the importance of supplying complete medical and welfare information—and of expecting decision-makers to engage with it. Migration agents predict a rise in merits-review challenges where health-care access overseas is at issue. The Department of Home Affairs will now need to revisit internal guidance to ensure delegates weigh humanitarian factors consistently with ministerial directions. While the case concerns a single applicant, its reasoning applies across visa subclasses wherever decision-makers balance community-protection against individual hardship. Practical takeaway: Employers planning to rotate staff offshore should maintain detailed records of medical support available in host countries, as this evidence can prove pivotal if a Resident Return visa is later questioned.
Source: High Court of Australia
